Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossella Riccioni

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|October 11, 2007
Hairy Cell LeukemiaRossella Riccioni, Sara Galimberti, Mario Petrini
Acta Haematologica|March 23, 2004
Expansion of TcRalphabeta+CD3+CD4-CD8- (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndromeGiovanni Carulli, Ginetta Lagomarsini, Antonio Azzarà, et al.
American Journal of Hematology|December 22, 2005
Primary lymphoma of the bladder: case reportRossella Riccioni, Giovanni Carulli, Maurizio de Maria, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 20, 2004
Bilateral primary renal lymphoma treated by surgery and chemotherapyAdamasco Cupisti, Rossella Riccioni, Giovanni Carulli, et al.
Leukemia Research|January 2, 2007
PEG-Filgrastim activity on granulocyte functionsRita Fazzi, Enrico Orciuolo, Luisa Trombi, et al.
Frontiers in Medicine|August 28, 2020
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE ProtocolEnrico Capochiani, Bruno Frediani, Giorgio Iervasi, et al.
British Journal of Haematology|March 10, 2026
Incidence of severe COVID-19 in patients with chronic lymphocytic leukaemia or indolent B-cell non-Hodgkin lymphoma who received vaccination and pre-exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana LinfomiGian Matteo Rigolin, Stefano Soddu, Riccardo Dondolin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|October 11, 2007
Hairy Cell LeukemiaRossella Riccioni, Sara Galimberti, Mario Petrini
Acta Haematologica|March 23, 2004
Expansion of TcRalphabeta+CD3+CD4-CD8- (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndromeGiovanni Carulli, Ginetta Lagomarsini, Antonio Azzarà, et al.
American Journal of Hematology|December 22, 2005
Primary lymphoma of the bladder: case reportRossella Riccioni, Giovanni Carulli, Maurizio de Maria, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 20, 2004
Bilateral primary renal lymphoma treated by surgery and chemotherapyAdamasco Cupisti, Rossella Riccioni, Giovanni Carulli, et al.
Leukemia Research|January 2, 2007
PEG-Filgrastim activity on granulocyte functionsRita Fazzi, Enrico Orciuolo, Luisa Trombi, et al.
Frontiers in Medicine|August 28, 2020
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE ProtocolEnrico Capochiani, Bruno Frediani, Giorgio Iervasi, et al.
British Journal of Haematology|March 10, 2026
Incidence of severe COVID-19 in patients with chronic lymphocytic leukaemia or indolent B-cell non-Hodgkin lymphoma who received vaccination and pre-exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana LinfomiGian Matteo Rigolin, Stefano Soddu, Riccardo Dondolin, et al.
Pageof 1